b5media.com

Advertise with us

Enjoying this blog? Check out the rest of the Health & Wellness Channel Subscribe to this Feed

Genetics and Health

Warfarin Sensitivity DNA Test

by Hsien Hsien Lei, PhD on November 15th, 2006

Kimball Genetics, Inc. has launched the Warfarin Sensitivity DNA Test for routine clinical use early next year. It tests for variations in the CYP2C9 and VKORC1 genes which play a role in determining a person’s sensitivity to warfarin via metabolism and anticoagulation processes, respectively. Warfarin (brand name Coumadin) prevents blood clots and is typically prescribed for patients who are experiencing irregular heartbeat or those who’ve had a heart attack or heart valve replace surgery.

The Warfarin Sensitivity DNA Test that Kimball offers informs the prescriber about the presence of genetic risk factors for overanticoagulation and should help achieve the correct maintenance dose faster. It is also likely to increase the safety and efficacy of warfarin treatment. The DNA test identifies patients who are sensitive to warfarin and who therefore: 1) require a lower dose to achieve a target INR, 2) may be at an increased risk for bleeding complications, and 3) without the DNA test, would require a longer period of time to achieve stable warfarin dosing.

I hear the bells of personalized medicine tolling once more.

Medical News Today, November 15, 2006

Technorati Tags: , , , , , , , , , ,

POSTED IN: General Genetics and Health, Genetic Testing

7 opinions for Warfarin Sensitivity DNA Test

Have an opinion? Leave a comment:




Site Meter
Close
E-mail It